711 reports of this reaction
2.6% of all HYDROXYZINE HYDROCHLORIDE reports
#5 most reported adverse reaction
RASH is the #5 most commonly reported adverse reaction for HYDROXYZINE HYDROCHLORIDE, manufactured by ANI Pharmaceuticals, Inc.. There are 711 FDA adverse event reports linking HYDROXYZINE HYDROCHLORIDE to RASH. This represents approximately 2.6% of all 26,851 adverse event reports for this drug.
Patients taking HYDROXYZINE HYDROCHLORIDE who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH is a less commonly reported adverse event for HYDROXYZINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to rash, the following adverse reactions have been reported for HYDROXYZINE HYDROCHLORIDE:
The following drugs have also been linked to rash in FDA adverse event reports:
RASH has been reported as an adverse event in 711 FDA reports for HYDROXYZINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH accounts for approximately 2.6% of all adverse event reports for HYDROXYZINE HYDROCHLORIDE, making it a notable side effect.
If you experience rash while taking HYDROXYZINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.